Inhibitors of cyclooxygenase-2 (COX-2) suppressed the proliferation and differentiation of human leukaemia cell lines

被引:62
|
作者
Nakanishi, Y [1 ]
Kamijo, R [1 ]
Takizawa, K [1 ]
Hatori, M [1 ]
Nagumo, M [1 ]
机构
[1] Showa Univ, Sch Dent, Dept Oral & Maxillofacial Surg 2, Ota Ku, Tokyo 1458515, Japan
关键词
U-937; ML-1; COX-2; inhibitor; NS-398; nabumetone; proliferation; differentiation; G0/G1; arrest;
D O I
10.1016/S0959-8049(01)00160-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prostaglandins (PG) are known to play important roles in the proliferation and differentiation of leukaemia cells. The effect of the inhibitors of cyclooxygenase-2 (COX-2), a rate-limiting enzyme for the synthesis of PG, on the proliferation and differentiation of leukaemia cell lines was investigated. COX-2 inhibitors, NS-398 and nabumetone, suppressed the proliferation of U-937 and ML-1 cells by inducing a G0/G1 cell-cycle arrest. Cell-cycle arrest induced by these COX-2 inhibitors was not associated with an upregulation of the cyclin-dependent kinase inhibitors. COX-2 inhibitors also inhibited the differentiation of these cells induced by interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and retinoic acid (RA). Treatment with NS-398 did not suppress the levels of PGs produced by these cells. Although COX-2 antisense oligonucleotide showed a similar inhibitory effect on these cells, its inhibitory effect was smaller than that of NS-398, These results suggest that COX-2 inhibitors may suppress the proliferation and differentiation of leukaemia cells both via COX-2-dependent and -independent pathways. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1570 / 1578
页数:9
相关论文
共 50 条
  • [21] The effect of a selective cyclooxygenase-2 (COX-2) inhibitor on the proliferative rate of retinoblastoma cell lines
    Souza, JP
    Correa, ZM
    Marshall, JCA
    Coutinho, AB
    Martins, MC
    Burneir, MN
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [22] Cyclooxygenase-2 (COX-2) is directly involved but not decisive in proliferation of human hepatocellular carcinoma cells
    Park, JW
    Park, JE
    Lee, JA
    Lee, CW
    Kim, CM
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (03) : 184 - 192
  • [23] Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: Recent advancement
    Li, Shuangshuang
    Jiang, Min
    Wang, Lu
    Yu, Shuwen
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 129
  • [24] Cyclooxygenase-2 expression with maintenance of prostacyclin synthesis in two human endothelial cell lines. A new model to study Cox-2 inhibitors
    Pich, I
    Vidal, F
    Lopez, S
    Badimon, L
    deCastellarnau, C
    THROMBOSIS AND HAEMOSTASIS, 1997, : S2355 - S2355
  • [25] Cyclooxygenase-2 (Cox-2) in Newborn Lung
    P Lassus
    H Wolff
    S Andersson
    Pediatric Research, 1999, 45 (6) : 887 - 887
  • [26] Cancer and cyclooxygenase-2 (COX-2) inhibition
    Evans, JF
    Kargman, SL
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (06) : 627 - 634
  • [27] Cyclooxygenase-2 (Cox-2) expression in lymphomas
    Hazar, B
    Ergin, M
    Seyrek, E
    Erdogan, E
    Tuncer, I
    Hakverdi, S
    LEUKEMIA & LYMPHOMA, 2004, 45 (07) : 1395 - 1399
  • [28] Cyclooxygenase-2 (COX-2) expression in retinoblastoma
    Mendez, MC
    Fernandes, L
    Caissie, AL
    Callejo, SA
    Burnier, MN
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U605 - U605
  • [29] Cyclooxygenase-2 (COX-2) in newborn lung
    Lassus, P
    Wolff, H
    Andersson, S
    PEDIATRIC RESEARCH, 1999, 45 (06) : 887 - 887
  • [30] Cyclooxygenase-2 (COX-2) As a Predictive Marker for the Use of COX-2 Inhibitors in Advanced Non-Small-Cell Lung Cancer
    Edelman, Martin J.
    Hodgson, Lydia
    Wang, Xiaofei
    Kratzke, Robert A.
    Vokes, Everett E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (16) : 2019 - 2020